do you have to use glp-1 forever Take Forever? Understanding the Long-Term Commitment of Weight Loss Medications – PlexusDx Do you have to stay

Learn why semaglutide & tirzepatide slow digestion, and discover lifestyle tips + Digest by Strive for natural, lasting relief.

Materials and Methods This was a single centre retrospective observational study conducted at a Swiss bariatric reference centre

Discover how tirzepatide and metformin together optimize type 2 diabetes control through complementary mechanisms

Understand the risk factors, warning signs, and how personalized tirzepatide therapy from PlexusDx supports safer weight loss outcomes

Learn about the brands, retailers, and products leading the pack.

The GLP-1 receptor agonist semaglutide reduces risks of kidney function loss, kidney failure, cardiovascular events, cardiovascular death and all-cause mortality in people with CKD and T2DM Ongoing clinical and mechanistic studies are expected to expand use of GLP-1 receptor agonists, GLP-1/GIP and other metabolic hormones for the treatment of CKD At the moment the most complete data is available for semaglutide from SUSTAIN-6 and FLOW trial which is the only trial with primary renal outcome in T2DM patients out of all GLP-1 RA Very good data for renal outcomes as secondary ones available for GLP-1 RAs dulaglutide and liraglutide and GLP-1/GIP RA tirzepatide, Very interesting and positive data from mechanistic REMODEL trial with semaglutide in T2DM patients presented but not yet published (reduced perirenal fat, rernal fibrosis and much more) Based on following excellent papers: #glp1 #gip #semaglutide #tirzepatide #liraglutide #dulaglutide #kidney #ckd #chronickidneydisease #cardiovascularcomplications